Research Papers

25 of 207 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Transbronchial cryobiopsy proven amyloid diffuse cystic lung disease complicating a transthyretin mutated (ATTRm) amylo…
Gaultier S; Puscas T; Pastre J; Gibault L; Arlet JB; Cauquil C; Michon A.
Ther Adv Respir Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
REALizing and improving management of stable COPD in China: results of a multicentre, prospective, observational study …
Yang T; Cai B; Cao B; Kang J; Wen F; Chen Y; Jian W; Wang C.
Ther Adv Respir Dis (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Predictors of poor clinical outcomes including in-hospital death and low ability to perform activities of daily living …
Murakami Y; Yasui H; Sato J; Uto T; Inui N; Suda T; Imokawa S.
Ther Adv Respir Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The effects of upper limb exercise training on upper limb muscle strength in people with chronic obstructive pulmonary …
Karagiannis C; Savva C; Korakakis V; Ploutarchou G; Adamide T; Georgiou A; Xanthos T.
Ther Adv Respir Dis (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Determination of patient-specific airway stent fit using novel 3D reconstruction measurement techniques: a 4-year follo…
Ntiamoah P; Gildea TR; Baiera A.
Ther Adv Respir Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The therapeutic potential of quercetin for cigarette smoking-induced chronic obstructive pulmonary disease: a narrative…
Ding K; Jiang W; Zhan W; Xiong C; Chen J; Wang Y; Jia H; Lei M.
Ther Adv Respir Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The role of prone positioning in patients with SARS-CoV-2-related respiratory failure in non-intensive care unit.
Graziani M; Barbieri G; Maraziti G; Falcone M; Fiaccadori A; Corradi F; Ghiadoni L; Satula K; Noumi G; Becattini C.
Ther Adv Respir Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Exacerbation in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohor…
Yang T; Cai B; Cao B; Kang J; Wen F; Chen Y; Jian W; Wang C.
Ther Adv Respir Dis (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
A prospective study on the long-term storage of sputum and the recovery of nontuberculous mycobacteria.
Kwon BS; Park JS; Shin JA; Kim ES; Lim SY; Song MJ; Kim YW; Kim HJ; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee CT; Lee JH.
Ther Adv Respir Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Bronchoscopic interventions for bronchopleural fistulas.
Jin L; Li Y.
Ther Adv Respir Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Oxygen insufflation through the bronchoscope channel for sedation-induced hypoxia: safe and effective.
Abouzgheib W; Miller H; Bartter T.
Ther Adv Respir Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Characteristics of initiators of budesonide/glycopyrrolate/formoterol for treatment of chronic obstructive pulmonary di…
Portillo EC; Pollack M; Lee I; Sun K; Zhao X; Kruse L; Feigler N; Patel S; Near AM.
Ther Adv Respir Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Similarities and differences between the cough suppression test and the cough challenge test.
Zhao K; Bai X; Wen S; Wang S; Xu X; Yu L.
Ther Adv Respir Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Effects of exercise-based pulmonary rehabilitation on severe/very severe COPD: a systematic review and meta-analysis.
He W; Wang J; Feng Z; Li J; Xie Y.
Ther Adv Respir Dis (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Trends of therapy in the treatment of asthma.
Lv X; Gao Z; Tang W; Qin J; Wang W; Liu J; Li M; Teng F; Yi; Dong J; Wei Y.
Ther Adv Respir Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The efficacy of <i>N</i>-acetylcysteine in chronic obstructive pulmonary disease patients: a meta-analysis.
Huang C; Kuo S; Lin L; Yang Y.
Ther Adv Respir Dis (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Real-life therapeutic effects of beclomethasone dipropionate/formoterol fumarate/glycopyrronium combined triple therapy…
Pelaia C; Procopio G; Rotundo FL; Deodato MR; Ferrante Bannera A; Tropea FG; Cancelliere A; Vatrella A; Pelaia G.
Ther Adv Respir Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Healthcare use and medical cost before and after diagnosis of nontuberculous mycobacterial infection in Korea: the Nati…
Lee SW; Chang S; Park Y; Kim S; Sohn H; Kang YA.
Ther Adv Respir Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severit…
Kahnert K; Jörres RA; Kauczor HU; Alter P; Trudzinski FC; Herth F; Jobst B; Weinheimer O; Nauck S; Mertsch P; Kauffmann-Guerrero D; Behr J; Bals R; Watz H; Rabe KF; Welte T; Vogelmeier CF; Biederer J.
Ther Adv Respir Dis (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Cardiovascular and cerebrovascular-associated mortality in patients with preceding bronchiectasis exacerbation.
Lee SC; Son KJ; Hoon Han C; Park SC; Jung JY.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Clinical significance of acute exacerbation in interstitial lung disease with antineutrophil cytoplasmic antibody: an i…
Wu T; Zhang Y; Cen Z; Ying Y; Sun C; Lv C; Ding Q.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The role of autophagy in idiopathic pulmonary fibrosis: from mechanisms to therapies.
Yue YL; Zhang MY; Liu JY; Fang LJ; Qu YQ.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Association of dipeptidyl peptidase-4 inhibitor use and the risk of asthma development among type 2 diabetes patients.
Li PF; Chung CH; Liu JS; Lu CH; Su SC; Kuo FC; Ho LJ; Chen KC; Su YT; Chu NF; Lee CH; Hsieh CH; Hung YJ; Lin FH; Chien WC; Liang YJ.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Combination of anti-glycopeptidolipid-core IgA antibody and clinical features for diagnosing potential nontuberculous m…
Iwasaki T; Yamaguchi F; Hayashi M; Kobayashi H; Hirata K; Miyo K; Kondo C; Kanzaki M; Tei K; Abe T; Sakakura S; Inoue D; Yamazaki Y; Tateno H; Yokoe T; Shikama Y.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Real-world evidence of subcutaneous treprostinil use in pulmonary arterial hypertension in Argentina.
Lescano A; Giacommi G; Botta CE; Soricetti J; Rodriguez M; Vargas Mielles P; Diez F.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared